Analysis: How New Federal Policies and Lower List Prices Are Reducing 340B Savings

Federal policies pushing drug manufacturers to lower wholesale acquisition costs for medications are inadvertently impacting providers through less 340B revenue, sources said.
…
Read More »

Site Footer Live